Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
J Clin Hypertens (Greenwich). 2021 Mar;23(3):606-613. doi: 10.1111/jch.14239. Epub 2021 Mar 10.
Increased heart rate is a predictor of cardiovascular disease, heart failure, and all-cause mortality. In those with high heart rates, interventions for heart rate reduction have been associated with reductions in coronary events. Asia is a diverse continent, and the prevalences of hypertension and cardiovascular disease differ among its countries. The present analysis of AsiaBP@Home study data investigated differences among resting heart rates (RHRs) in 1443 hypertensive patients from three Asian regions: East Asia (N = 595), Southeast Asia (N = 680), and South Asia (N = 168). This is the first study to investigate self-measured RHR values in different Asian countries/regions using the same validated home BP monitoring device (Omron HEM-7130-AP/HEM-7131-E). Subjects in South Asia had higher RHR values compared with the other two regions, and the regional tendency found in RHR values was different from that found in BP values. Even after adjusting for age, sex, BMI, habitual alcohol consumption, current smoking habit, shift worker, hyperlipidemia, diabetes, chronic kidney disease, history of heart failure, and beta-blocker use, both office and home RHR values in South Asia were the highest among Asia (mean values ± SE of office: East Asia [E] 75.2 ± 1.5 bpm, Southeast Asia [Se] 76.7 ± 1.5 bpm, South Asia [S] 81.9 ± 1.4 bpm; home morning: [E] 69.0 ± 1.2 bpm, [Se] 72.9 ± 1.2 bpm, [S] 74.9 ± 1.1 bpm; home evening: [E] 74.6 ± 1.2 bpm, [Se] 78.3 ± 1.2 bpm, [S] 83.8 ± 1.1 bpm). Given what is known about the impact of RHR on heart disease, our findings suggest the possible benefit of regionally tailored clinical strategies for cardiovascular disease prevention.
心率增快是心血管疾病、心力衰竭和全因死亡率的预测指标。在心率较高的患者中,降低心率的干预措施与冠状动脉事件的减少相关。亚洲是一个多样化的大陆,其各国的高血压和心血管疾病患病率存在差异。本研究对亚洲 BP@Home 研究数据进行了分析,调查了来自东亚(N=595)、东南亚(N=680)和南亚(N=168)的 1443 名高血压患者的静息心率(RHR)差异。这是第一项使用相同经过验证的家庭血压监测设备(欧姆龙 HEM-7130-AP/HEM-7131-E)调查不同亚洲国家/地区自我测量 RHR 值的研究。与其他两个地区相比,南亚的 RHR 值较高,而且 RHR 值的地区趋势与 BP 值的地区趋势不同。即使在校正了年龄、性别、BMI、习惯性饮酒、当前吸烟习惯、轮班工作、血脂异常、糖尿病、慢性肾脏病、心力衰竭病史和β受体阻滞剂使用情况后,南亚的办公室和家庭 RHR 值在亚洲也是最高的(平均值±SE 的办公室:东亚 [E] 75.2±1.5 bpm,东南亚 [Se] 76.7±1.5 bpm,南亚 [S] 81.9±1.4 bpm;家庭早晨:[E] 69.0±1.2 bpm,[Se] 72.9±1.2 bpm,[S] 74.9±1.1 bpm;家庭晚上:[E] 74.6±1.2 bpm,[Se] 78.3±1.2 bpm,[S] 83.8±1.1 bpm)。鉴于心率对心脏病的影响,我们的研究结果表明,针对心血管疾病预防的区域性临床策略可能具有潜在益处。